You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 143 No. 5, May 2008 TABLE OF CONTENTS
  Archives
  •  Online Features
  Paper
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Cardiovascular/ Cardiothoracic Surgery
 •Surgical Physiology, Other
 •Transplantation, Other
 •Cardiovascular Disease/ Myocardial Infarction
 •Alert me on articles by topic

Functional Small-Diameter Human Tissue–Engineered Arterial Grafts in an Immunodeficient Mouse Model

Preliminary Findings

Gregory N. Nelson, BS; Tamar Mirensky, MD; Matthew P. Brennan, MD; Jason D. Roh, BA; Tai Yi, MD; Yinong Wang, MD; Christopher K. Breuer, MD

Arch Surg. 2008;143(5):488-494.

Hypothesis  The immunodeficient (severe combined immunodeficiency beige [SCID/bg]) mouse model provides a useful model for investigating vascular neotissue formation in human tissue–engineered arterial conduits (TEAC).

Design  Human aortic smooth muscle cells and endothelial cells were statically seeded on porous biodegradable polymeric scaffolds for vascular tissue engineering. These 2-cell tissue-engineered vascular conduits were implanted into immunodeficient female mice as aortic interposition grafts. Grafts were evaluated over a 30-week course to investigate their patency and structure.

Setting  In vivo animal study.

Patients  Thirteen female C.B-17 SCID/bg mice.

Intervention  The TEACs implanted as infrarenal abdominal aortic interposition grafts.

Main Outcome Measures  Selective microcomputed tomography with intra-arterial contrast revealed graft patency and structure. Histological and immunohistochemical evaluations revealed cellularity and extracellular matrix composition. Species-specific immunohistochemical evaluation determined the source of cells within TEACs.

Results  All TEACs were patent without evidence of thrombosis or rupture over the 30-week course. Histological and immunohistochemical evaluation revealed a von Willebrand factor–positive luminal monolayer surrounded by concentric collagen-rich layers of {alpha}-smooth muscle actin–positive cells.

Conclusions  The SCID/bg mouse is a useful model for investigating vascular neotissue formation in human TEACs. We see evidence that these grafts remain patent while developing into vascular neotissue histologically similar to native aorta. This chimeric animal model also enables determination of seeded cell retention, providing insight into cellular mechanisms underlying neotissue formation.


Author Affiliations: Departments of Surgery (Messrs Nelson and Roh and Drs Mirensky, Brennan, Yi, Wang, and Breuer), Radiology (Dr Brennan), and Pathology (Dr Wang), and the Interdepartmental Program in Vascular Biology and Therapeutics (Messrs Nelson and Roh and Drs Mirensky, Brennan, Yi, and Breuer), Yale University School of Medicine, New Haven, Connecticut.







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.